ASCO 2024

May 31 - June 04, 2024
Chicago, IL

American Society of Clinical Oncology 2024

Explore more Oncology congress materials

Results(2)

Hematology-Oncology

Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer: Overall Survival and Longer Follow-Up From the Phase 2b HERIZON-BTC-01 Study

Author(s): Shubham Pant, MD Anderson Cancer Center, et al.

Recombinant Erwinia Asparaginase (JZP458) in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma (ALL/LBL): Post Hoc Analysis of Adverse Events of Interest From AALL1931

Author(s): Etsuko Aoki, Jazz Pharmaceuticals, Palo Alto, CA, USA, et al.

Disclaimer

This AI model is continuing to learn and its responses are based on learned data patterns. It should not replace professional judgment. Please verify the information before use, and feedback is welcome to improve its accuracy.

Please do not include personal or confidential information in your searches. For information on how to report an adverse event or product complaint for a Jazz product, please visit: https://www.jazzpharma.com/medicines/drug-safety/.